JAMES F EMIGH Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JAMES F EMIGH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES F EMIGH. JAMES F EMIGH is VP Corporate Development in ACURA PHARMACEUTICALS, INC ($ACUR) and VP Marketing & Administration in ACURA PHARMACEUTICALS, INC ($ACUR) and VP, Corporate Development in ACURA PHARMACEUTICALS, INC ($ACUR).
Latest Insider Trading Transactions of JAMES F EMIGH
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2021 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP, Corporate Devel ... | Option Exercise | M | 0.15 | 20,000 | 3,020 | 0 | |
| Feb 26 2021 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP, Corporate Devel ... | Payment of Exercise | F | 0.40 | 7,550 | 3,020 | 474,042 | 481.6 K to 474 K (-1.57 %) |
| Feb 26 2021 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP, Corporate Devel ... | Buy | M | 0.15 | 20,000 | 3,020 | 481,592 | 461.6 K to 481.6 K (+4.33 %) |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP, Corporate Devel ... | Option Exercise | M | 0.01 | 20,000 | 200 | 44,666 | |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP, Corporate Devel ... | Option Exercise | M | 0.01 | 4,667 | 47 | 64,666 | |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP, Corporate Devel ... | Payment of Exercise | F | 0.21 | 7,402 | 1,554 | 461,592 | 469 K to 461.6 K (-1.58 %) |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP, Corporate Devel ... | Buy | M | 0.00 | 24,667 | 0 | 468,994 | 444.3 K to 469 K (+5.55 %) |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP, Corporate Devel ... | Option Exercise | M | 0.01 | 4,667 | 47 | 69,333 | |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP, Corporate Devel ... | Buy | M | 0.00 | 4,667 | 0 | 444,327 | 439.7 K to 444.3 K (+1.06 %) |
| Dec 17 2018 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Option Exercise | A | 0.15 | 20,000 | 3,020 | 20,000 | |
| Dec 17 2018 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Option Exercise | A | 0.01 | 60,000 | 600 | 60,000 | |
| Dec 18 2017 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Buy | P | 0.10 | 400,000 | 40,000 | 439,660 | 39.7 K to 439.7 K (+1,008.57 %) |
| Dec 11 2017 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Option Exercise | A | 0.00 | 14,000 | 0 | 14,000 | |
| Aug 10 2017 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Option Exercise | A | 0.45 | 14,000 | 6,300 | 14,000 | |
| Dec 12 2016 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Option Exercise | A | 0.92 | 14,000 | 12,810 | 14,000 | |
| Dec 14 2015 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Option Exercise | A | 2.01 | 20,000 | 40,200 | 20,000 | |
| Dec 12 2014 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Option Exercise | A | 0.52 | 54,000 | 28,080 | 54,000 | |
| May 19 2014 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Buy | P | 1.21 | 15,000 | 18,149 | 198,304 | 183.3 K to 198.3 K (+8.18 %) |
| Jan 27 2014 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Option Exercise | M | 1.30 | 6,225 | 8,093 | 0 | |
| Jan 27 2014 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Buy | M | 1.30 | 6,225 | 8,093 | 183,304 | 177.1 K to 183.3 K (+3.52 %) |
| Dec 13 2013 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Option Exercise | A | 1.55 | 37,500 | 58,125 | 37,500 | |
| May 06 2013 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Option Exercise | M | 1.30 | 6,225 | 8,093 | 6,225 | |
| May 06 2013 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Buy | M | 1.30 | 6,225 | 8,093 | 177,079 | 170.9 K to 177.1 K (+3.64 %) |
| Jan 03 2013 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Payment of Exercise | F | 2.22 | 6,596 | 14,643 | 170,854 | 177.5 K to 170.9 K (-3.72 %) |
| Dec 17 2012 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Option Exercise | A | 2.61 | 40,000 | 104,400 | 40,000 | |
| Jan 30 2012 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Option Exercise | M | 1.30 | 6,225 | 8,093 | 12,450 | |
| Jan 30 2012 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Buy | M | 1.30 | 6,225 | 8,093 | 177,450 | 171.2 K to 177.5 K (+3.64 %) |
| Dec 19 2011 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Corporate Develo ... | Option Exercise | A | 3.72 | 35,000 | 130,200 | 35,000 | |
| Aug 15 2011 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Marketing & Admi ... | Buy | P | 2.64 | 714 | 1,885 | 171,225 | 170.5 K to 171.2 K (+0.42 %) |
| Aug 15 2011 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Marketing & Admi ... | Buy | P | 2.62 | 400 | 1,048 | 170,511 | 170.1 K to 170.5 K (+0.24 %) |
| Aug 15 2011 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Marketing & Admi ... | Buy | P | 2.61 | 300 | 783 | 170,111 | 169.8 K to 170.1 K (+0.18 %) |
| Aug 15 2011 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Marketing & Admi ... | Buy | P | 2.60 | 2,200 | 5,720 | 169,811 | 167.6 K to 169.8 K (+1.31 %) |
| Aug 15 2011 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Marketing & Admi ... | Buy | P | 2.59 | 300 | 777 | 167,611 | 167.3 K to 167.6 K (+0.18 %) |
| Aug 15 2011 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Marketing & Admi ... | Buy | P | 2.58 | 986 | 2,544 | 167,311 | 166.3 K to 167.3 K (+0.59 %) |
| Aug 15 2011 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Marketing & Admi ... | Buy | P | 2.56 | 100 | 256 | 166,325 | 166.2 K to 166.3 K (+0.06 %) |
| Jan 24 2011 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Marketing & Admi ... | Option Exercise | M | 1.30 | 6,225 | 8,093 | 18,675 | |
| Jan 24 2011 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Marketing & Admi ... | Buy | M | 1.30 | 6,225 | 8,093 | 189,225 | 183 K to 189.2 K (+3.40 %) |
| Dec 20 2010 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Marketing & Admi ... | Option Exercise | A | 3.02 | 24,000 | 72,480 | 24,000 | |
| Apr 27 2009 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Marketing & Admi ... | Option Exercise | A | 6.29 | 72,000 | 452,880 | 72,000 | |
| Apr 27 2009 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Marketing & Admi ... | Grant | A | 0.00 | 18,000 | 0 | 160,000 | 142 K to 160 K (+12.68 %) |
| May 23 2008 | ACUR | ACURA PHARMACEUTIC ... | EMIGH JAMES F | VP Marketing & Admi ... | Option Exercise | A | 9.87 | 80,000 | 789,600 | 80,000 |
Page: 1